Conferences
Business & Financial Strategies for Molecular Diagnostics 2009 - Ft. Lauderdale, FL
02/02/09-02/04/09
Register Now • Download the Conference Brochure • Sessions • Workshops • Accreditation • Venue • Prices
The growth and profitability of the U.S. molecular diagnostic testing market continues to accelerate, making it the most desirable area of the United States’ $60+ billion clinical laboratory industry. Washington G-2 Reports values molecular diagnostics in the U.S. at $4.5 billion in 2009 and estimates that it will continue to grow by roughly 19 percent per year for the next three years. Find out how you can harness this market’s emerging science, new business models, and consumer demand to best grow your lab.
Washington G-2 Reports 2009 Molecular Diagnostics Conference will provide expert insight and advice on how laboratories can and are successfully integrating molecular diagnostics into their business strategies given the current regulatory and business environment.
Here are Sessions Scheduled for February 3 & 4:
Keynote Address: Molecular Diagnostics: From Revolution to Mainstream to Genomic Medicine
Daniel H. Farkas, PhD, HCLD, Vice President, Clinical Diagnostics, Sequenom Center for Molecular Medicine
G-2's Molecular Market Overview
Stephanie Murg, Editor, Diagnostic Testing and Technology Report, Washington G-2 Reports
Selecting the Best Molecular Platform for Your Laboratory
John Greg Howe, PhD, Assistant Professor of Laboratory Medicine; Director, Molecular Diagnostics Laboratory, Yale University
Case Study: Molecular Diagnostics at St. Luke's Hospital
Jane M. Rachel, MT(ASCP), MA, Director of Education and Scientific Development; Manager, Molecular Diagnostics and Flow Cytometry, Saint Luke's Hospital
Case Study: Molecular Diagnostics at Spectrum Health Advanced Technology Laboratories
Kim Collison MSA, MT(ASCP), Lab Manager, Spectrum Health, Advanced Technology Laboratories
Building a Better Molecular Test Menu
Lynnette C. Savaloja, SCT(ASCP), Cytology Technical Supervisor, Regions Hospital Pathology Department
E. Blair Holladay, PhD, SCT(ASCP), Vice President for Scientific Activities and Executive Director; Board of Registry, American Society for Clinical Pathology
Applying Automation to Select and Medically Justify MDx Tests
Scott Liff, Vice President, Laboratory Services John Muir/Mt. Diablo Health System
Billing and Reimbursement
Diana Voorhees, MA, CLS, MT, SH, CLCP, Principal/CEO, DV & Associates, Inc.
Business and Financial Strategies for Molecular Diagnostics
Bryan Moore, PhD, MBA, Marketing Manager, Roche Diagnostics
Genetic Counseling and the Clinical Laboratory
Angela Trepanier, MS, CGC, President, National Society of Genetic Counselors; Director, Genetic Counseling Program; Assistant Professor, Clinical Center for Molecular Medicine and Genetics, Wayne State University School of Medicine
Commercializing Molecular Diagnostics: Opportunities and Obstacles
David S. Lester, PhD, Executive Vice President of Corporate Development, Gene Express
Molecular Testing for Personalized Healthcare
Lewis H. Bender, CEO, Interleukin Genetics
PGx in the Laboratory: Choosing and Using Pharmacogenomic Tests
Domnita Crisan, MD, Medical Director of Molecular Diagnostics, William Beaumont Hospital
Molecular Diagnostics Regulatory Update
Alberto Gutierrez, PhD, Director, Office of In Vitro Diagnostic Device Evaluation and Safety, U.S. Food & Drug Administration, Regulatory Issues (invited)
Molecular Diagnostics for Cancer: Balancing Focus and Growth at NeoGenomics
Robert P. Gasparini, MS, President and Chief Scentific Officer, NeoGenomics
Next Wave: Molecular Meets Point of Care
David Ludvigson, President and Chief Operating Officer, Nanogen
Ensuring the Future of the Molecular Workforce
Panel Discussion: The Future of Molecular Diagnostics
Doug Brown, Managing Director, Wachovia
David Ludvigson, President and Chief Operating Officer, Nanogen
Robert P. Gasparini, MS, President and Chief Scentific Officer, NeoGenomics
Pre-Conference Workshop A - Monday, February 2, 2009, 8:30-12:00
Molecular 101: Starting Up and Running a Molecular Lab
John Greg Howe, PhD, Assistant Professor of Laboratory Medicine; Director, Molecular Diagnostics Laboratory, Yale University
Laurie Huard, MT(ASCP) FACHE, Laboratory Site Director, Saint John's Health System
Lynnette C. Savaloja, SCT(ASCP), Cytology Technical Supervisor, Regions Hospital Pathology Department
Pre-Conference Workshop B - Monday, February 2, 2009, 1:00-4:30
Coding, Billing and Payment for Molecular Assays
Diana Voorhees, MA, CLS, MT, SH, CLCP, Principal/CEO, DV & Associates, Inc.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Pathology Service Associates (PSA), LLC and Washington G-2 Reports. PSA, LLC is accredited by the ACCME to provide continuing medical education for physicians.
PSA designates this educational activity for maximum of 19.5 hours of AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in this activity.
Washington G-2 Reports is approved as a provider of PACE contact hour credit for clinical laboratory professionals, including Florida or California licensees, by the American Society for Clinical Laboratory Science (ASCLS). Business & Financial Strategies for Molecular Diagnostics 2009 is expected to be approved for up to 19.0 continuing education credit hours.
Venue: Hyatt Regency Pier Sixty-Six, 2301 S.E. 17th Street Causeway, Fort Lauderdale, FL 33316. Ph: 800-327-3796.
Mention you're attending Washington G-2 Reports Molecular Diagnostics Conference to take advantage of the special reduced room rate of $289 for a standard, single/double occupancy (plus taxes).
Deadline to guarantee reduced rate: Friday, January 9, 2009 (providing group room block has not been filled); thereafter (or if the block is filled), rooms are subject to availability.
Hyatt Regency Pier Sixty-Six is a timeless jewel among Fort Lauderdale hotels and resorts, renowned for its dazzling waterfront views, fine cuisine, and indulgent spa services. Set amid lush tropical acres along the Intracoastal Waterway, this breathtaking Fort Lauderdale Florida hotel provides the ideal getaway in the yachting capital of the world. Immerse yourself in boundless recreation at this resort-style luxury hotel in Fort Lauderdale, Florida – just moments from Port Everglades, the airport, and the convention center.
| Early Bird Subscriber Rate | Early Bird Non-Subscriber Rate | You Save | |
| Conference Only | $695 | $795 | - |
| Workshop Only | $445 | $445 | - |
| Conference & One Workshop | $940 | $1040 | $200 |
| Conference & Two Workshops | $1185 | $1285 | $400 |
The prices listed below are individual prices only. Your discount will be calculated automatically when you check out. See the grid above for combination pricing!
To Register, make a selection below or call John Watkins at 800-401-5937 ext. 4710 or email John at johnwatkins@ioma.com The Early Bird Rates Listed Below Expire on December 22nd!!
Download the Conference Brochure
Purchasing
Focus Areas |
Product Group |
 Washington G2 Medical Lab & Imaging Management |
Conferences & Professional Development Training |